Bone mineral testing device gains approval
Alara of Hayward, CA, has received 510(k) clearance from the FDA to market Alara MetriScan, a tabletop device that allows physicians to perform in-office bone and mineral density testing on patients at risk for osteoporosis and related bone
Alara of Hayward, CA, has received 510(k) clearance from the FDA to market Alara MetriScan, a tabletop device that allows physicians to perform in-office bone and mineral density testing on patients at risk for osteoporosis and related bone fracture.
The device scans a patients phalanges to estimate bone mineral density, which can be a predictor of osteoporosis and hip fracture risk.
The Alara MetriScan is a digital radiographic imaging device that uses storage phosphor technology to replace x-ray film as a radiation detector. Total radiation exposure to the patient is less than 5% of a typical dental x-ray, the firm says.
Alara is a privately held medical technology company that designs, manufactures, and markets medical imaging products based on storage phosphor technology.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
July 29th 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
